<DOC>
	<DOCNO>NCT02180958</DOCNO>
	<brief_summary>The main objective study assess safety 1 month embolization session efficacy : - 12 month post last embolization case treatment embolization - 12 month additional treatment neurosurgery - 36 month additional treatment radiosurgery</brief_summary>
	<brief_title>ONYX Evaluation Endovascular Treatment Cerebral Arteriovenous Malformations ( cAVM )</brief_title>
	<detailed_description />
	<mesh_term>Congenital Abnormalities</mesh_term>
	<mesh_term>Arteriovenous Malformations</mesh_term>
	<mesh_term>Hemangioma</mesh_term>
	<mesh_term>Intracranial Arteriovenous Malformations</mesh_term>
	<criteria>The patient present cerebral AVM ( already treat ) treat embolization Onyx whether associate cyanoacrylate base adhesive , The patient least 6 year old . During treatment period his/her cerebral AVM , patient participates study assess another medical device , another procedure drug . The patient and/or his/her legal representative ( applicable ) refuse give his/her consent collection process data require centralized followup . For patient refuse collection personal data , , reason non inclusion date implantation document . Any condition could prevent followup patient .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>cerebral arteriovenous malformation</keyword>
	<keyword>cAVM</keyword>
	<keyword>ONYX</keyword>
</DOC>